CURASEN
Dead / Abandoned — Abandoned — failure to respond (as of 30 Jul 2025)
What this means for you
This application is over — abandoned 30 Dec 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90075978
- Mark type
- Stylized text
- Filed
- 27 Jul 2020
- Published for opposition
- 10 Aug 2021
- Abandoned
- 30 Dec 2024
- Attorney of record
- Susan N. Acquista, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention, treatment and diagnosis of neurological diseases, namely, Parkinson's disease
Owner
- Curasen Therapeutics, Inc., San Carlos, CA, US
- Curasen Therapeutics, Inc., San Mateo, CA, US
Prosecution history
- 30 Jul 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 30 Jul 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 27 Sept 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 27 Sept 2024 — FINAL REFUSAL E-MAILED
- 27 Sept 2024 — SU - FINAL REFUSAL - WRITTEN
- 27 Sept 2024 — DIVISIONAL PROCESSING COMPLETE
- 29 Jun 2024 — DIVISIONAL REQUEST RECEIVED
- 26 Sept 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Jun 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Jun 2024 — TEAS REQUEST TO DIVIDE RECEIVED
- 01 Apr 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Apr 2024 — NON-FINAL ACTION E-MAILED
- 01 Apr 2024 — SU - NON-FINAL ACTION - WRITTEN
- 01 Apr 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 29 Mar 2024 — USE AMENDMENT FILED